Adrian Bot

Adrian Bot

Company: Capstan Therapeutics

Job title: Chief Scientific Officer


Panel Discussion: War of the Payloads – Addressing the Advantages & Disadvantages of Transient VS Direct Integration 12:00 pm

• Discussing the use of non-stable integration with a DNA payload for greater safety and control • Discussing the challenges associated with stable integration, including lack of control in the context of proliferated cells • Re-thinking re-dosing strategies for enhanced efficacy • Evaluating the implications of removing lymphodepletion for in-vivo approaches, and associated effects on…Read more

day: Day 2

Mastermind Session: Discussing the Translatable Applications of In- Vivo Therapeutics in Oncology, Autoimmunity, Infectious Disease & More 2:15 pm

• Deep dive session comparing and contrasting in vivo engineering of therapeutic cells to treat a wider range of disease indications including solid tumor, cardiovascular condition, IBD lupus, HIV and more • Discussing the blockbuster potential for in vivo approaches to bring lost lasting treatments to areas of high unmet needRead more

day: Day 2

Industry Leader’s Fireside Chat: Comparing Different Delivery Constructs to Pave the Future of Cell Therapy 8:45 am

An executive panel discussion from the industry leaders of the field to set the scene on the future of In Vivo approaches within the cell therapy space. Ask your questions live to understand the expert’s thoughts on key topics including: • Reviewing different platform technologies for reprogramming in-vivo human cells and tissues e.g LNP versus…Read more

day: Day 1

Chairman’s Opening Remarks 9:15 am

Read more

day: Day 2

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.